Tina Lien Vestland
Tina holds a M.Sc. and a Ph.D. from School of Pharmacy at the University of Oslo. Her areas of scientific expertise are within formulation with healthy lipids, oxidative stability and bioavailability.
Engaged by Omegatri since 2010 as Product Manager and Chief Technology Officer, she has in-depth knowledge of the capabilities of the Omegatri technology. As General Manager since 2014 she has followed selected products from the laboratory to the global market.
Helena Nyblom Munthe
Helena is M.D., Ph.D, and educated at the Sahlgrenska Academy at the University of Gothenburg. She is a specialist doctor in psychiatry and holds a Ph.D. in internal medicine.
Helena has many years clinical experience from both internal medicine and psychiatry. She has a great interest in preventive medicine and is the author of four health and lifestyle books published by Albert Bonniers Förlag and Lava Forlag.
Professor Jo Klaveness is one of the co-founders of Omegatri and is still active as advisor and in the owner group. He holds a Ph.D. and a M.Sc. in organic chemistry and a M.Sc. Pharm in pharmaceutical chemistry from the University of Oslo.
From 1983 to 1994, Dr. Klaveness served in various positions at Nycomed, including as Vice President in the research and development organization. He is currently CEO of Drug Discovery Laboratory AS in addition to a position as professor in medicinal chemistry at the School of Pharmacy of the University of Oslo.
Dr. Klaveness is the inventor of more than 150 patent families within the pharmaceutical and nutraceutical area, including main/co-inventor on all Omegatri patent applications
Morten has a MBA from the University of Wyoming. He has during 25 years in managing and board positions gathered a versatile experience within such industries as health (Stamina Group) and pharmaceuticals (Pronova BioPharma ASA).
Morten has considerable experience with omega-3 after holding positions in Pronova BioPharma, first as CFO from 2006 to 2009, thereafter as CEO from 2009 to the company was acquired by BASF in 2013.
Geir Kjetil Røttingsnes
Geir is an attorney at law specialized in commercial law. He holds a master of laws from the University of Oslo. Geir has experience from different industries and holds a number of board positions.
OmegaTri™ shall be a leading developer of tablets and powders containing omega-3 and other healthy fats, plain or in combinations with other active ingredients, protected by patentes methods and technologies. Contact us today! Download our brochure >>